TargetMol
Cambendazole is one of the most effective agents for the therapy of human strongyloidiasis. Cambendazole is a nematocide effective against a variety of gastrointestinal parasites in cattle, sheep, and horses.
More Information
Supplier Page
TargetMol
MN-64
5 mg
| Purity Not Available
TargetMol
MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.
More Information
Supplier Page
MN-64
50 mg
| Purity Not Available
TargetMol
MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.
More Information
Supplier Page
MN-64
10 mg
| Purity Not Available
TargetMol
MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.
More Information
Supplier Page
MN-64
100 mg
| Purity Not Available
TargetMol
MN-64 is a tankyrases inhibitor, showed 6 nM potency against tankyrase 1, isoenzyme selectivity, and Wnt signaling inhibition.
More Information
Supplier Page
SC66
5 mg
| 99.60%
TargetMol
APD597
10 mg
| 99.87%
TargetMol
APD597
5 mg
| 99.87%
TargetMol
TargetMol
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.
More Information
Supplier Page